ISSCA is back for the second year in a row after a brief hiatus due to Covid with its annual ISSCA World Congress Of Regenerative Medicine 2022 for the Advancement of Cellular Therapies and Technology in Istanbul, Turkey.

The congress concentrates on getting physicians together from all over the world with three full days of conferences and workshops, such as the aesthetic applications workshop and the clinical applications workshop. Throughout this event, physicians and researchers speak with panels to discuss the recent advancements in the quickly expanding field of regenerative medicine; top among these are:

●       Molecular biology.

●       New models of treatment in surgical and cosmetic applications.

●       The latest technological advancements hit the area.

This conference includes a panel on Cellgenic Exosomes, which stems from years of progress towards discovering a regenerative medicine development to reduce harsh operating room time. The accumulation of this data serves one purpose– more effective treatment of degenerative disease worldwide with up-to-date therapeutic applications of stem cells.

Additionally, the conference also discusses the legal terrain for the practice of regenerative medicine as it offers itself around the world, meaning multiple national governments have input to some degree. Lectures are held over the course of the day at this congress, which is part of ISSCA’s mission to sustain a paradigm shift from conventional healthcare answers to regenerative medicine and deliver the latest ingenious findings and expansions in all areas of stem cell research.

The conference is held at the elegant Hotel Hyatt Regency, located near Istanbul’s Ataturk Airport. The hotel offers guests the medley of convenience, culture, and comfort while touring the ancient city, Turkey’s epicenter of entertainment and rich history. Congress attendees will uncover sceneries such as the Hagia Sophia and the Blue Mosque.

ISSCA Vice President Benito Novas had this to say about the conference: “It feels amazing to be back out– after so long with lockdowns and traveling difficulties, we were wondering if we would have to wait even longer to host an event. But, of course, it’s been far from ideal– even if the world locks down, research continues, and breakthroughs come through in our field of regenerative medicine month after month. Our ISSCA Congresses provide a great opportunity to spread this information out to the physicians who need it the most, and we plan to host as many as we can before the end of the year.”

Join the group of doctors looking for new alternatives for their patients by registering today to partake in ISSCA’s forthcoming events! Get ready to scale up your knowledge!

For more info, visit our website at https://www.issca.us/, email info@stemcellsgroup.com, or call +1305 560 5337.

 
About International Society for Stem Cells Applications

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary society of physicians and scientists aspiring to treat diseases through advances in science, tech, and regenerative medicine. ISSCA helps its members through advancements made to the specialty of regenerative medicine.

Regenerative medicine standards and certifications are critical, which is why ISSCA delivers certificate training worldwide. The objective is to inspire more doctors to practice regenerative medicine and open it globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

First-of-its-kind Cellular Therapy Training for doctors and medical practitioners in Pakistan

Newswise — Miami, FL –March 9th, 2022- The International Society for Stem Cell Applications (ISSCA) and Global Stem Cells Group (GSCG) today announced a new partnership with Ramzan Ali Syed Hospital  (RASC) to develop autologous bone marrow stem cell and exosome-based cell therapies and advance new therapeutic options for patients in the region. 

“Regenerative medicine is a fast-paced field that is growing exponentially every year as more and more research is being conducted and products are being used in clinics and doctors’ offices worldwide. -Said- Benito Novas  Managing director of the International Society for Stem Cell Applications. We are very proud to be able to collaborate with our hosts in Pakistan for the development of this medical specialty”. 

To stay abreast of current research, Ramzan Ali Syed Hospital partners with organizations like ISSCA and Global Stem Cells Group to provide continuing education opportunities for the doctors and specialists in Pakistan who want to learn more about how they can incorporate cellular therapies into their practice and help more patients with the latest generation of biologics and regenerative medicine products.

The first physician training course will be held in Lahore, Pakistan on March 30th – 31st & April 1st. Attendees will receive hands-on training on current protocols for MSC’s derived stem cell therapies, Exosomes, Bone Marrow derived stem cells, and PRP treatments as well as information about the most recent clinical applications with cellular medicine.

“This is the first time that ISSCA and Ramzan Ali Syed Hospital join forces for a stem cell certification course in the country, and this partnership will allow for more courses to be held in the future. This collaboration was born out of a desire to bring new technologies and cutting-edge treatments to patients throughout the country”. Said Dr. Mehmood Shaukat, Head of Pediatric Surgery 

“With Pakistan’s Ramzan Ali Syed Hospital as the newest member of the ISSCA community, we look forward to strengthening our relationship with the country and offering more support within the region,” said Benito Novas, CEO of the Global Stem Cells Group and Managing Director of ISSCA USA. “We know there is a lot of potential for cell therapies to have a huge impact here. Our goal is always to help patients and doctors have access to the best possible care, no matter where they live.”

Physicians looking to offer regenerative medicine treatments can benefit from the ISSCA and Ramzan Ali Stem Cell Center trainings, which are conveniently held onsite at the Ramzan Ali Syed Hospital, To learn more about the onsite training for doctors and other opportunities offered by ISSCA, visit https://www.issca.us

About ISSCA
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology, and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally.  Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

About Ramzan Ali Syed Hospital 
Ramzan Ali Stem Cell Center is an all-inclusive healthcare facility in regenerative medicine located in the premises of Ramzan Ali Syed Hospital at 21 Temple Road, Lahore, Pakistan. It is a pioneering institution with a passion for the safety of all its patients. We will make sure to give you all the information you require to guide you in making better decisions for your health.

About GSCG
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.

Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/

December 24th, 2021: Stem Cell Center has opened a new location in Córdoba, Argentina. Looking to bring regenerative medicine technologies to Argentina, the grand opening of the center was attended by 80 attendees at the new IMEB facilities, and broadcast for viewers across Argentina and the rest of the world to stream online.

As a division of Global Stem Cells Group, Stem Cell Center is an international network of medical practices dedicated to bringing stem cell therapies to patients across the world. By uniting a group of medical practitioners in the field, they are able to provide training, equipment, and resources to practitioners who in turn offer research and knowledge to the community. As a group, they are continuously developing new treatments, making them available, and bringing the best possible care to patients in the pursuit of stem cell technology. 

The launch of the new facility brings the group one step closer to their shared goal of reducing human suffering across the world, now making strides to provide access to these medical technologies in Argentina. Each new launch contributes to the acceleration of the process of developing and translating stem cell research into treatments and therapies that are accessible to both patients and physicians. 

“Opening the center in Córdoba is a major step toward that goal, allowing us to give solutions to patients without drugs, instead manifesting the potential that lies within the body itself to trigger biological regeneration processes,” says Benito Novas, Founder of Global Stem Cells Group. This latest opening was made possible by a partnership and alliance between founder of Global Stem Cells Group, Benito Novas, and Director of IMEB, Doctor Luis Alejandro Mazzarini. 

“This inauguration marks the launch of the pursuit of regenerative medicine, cell therapy, and tissue engineering treatments in Córdoba,” says Benito Novas. “I founded the group in 2010, as an expert in marketing, life sciences, and healthcare development. At the time, I was interested in the new progress that was being made in the field and was eager to make them available to as wide an array of patients as possible across the world.” 

“We believe stem cell medicine is the future of the medical industry, and we work closely with regulators, policymakers, and medical professionals to foster this technology and harness the true potential.”

The seminal launch of this science, research and medical facility is one effort in the global mission of Stem Cell Center, who have announced a partnership with Bioscience Cell factory, offered training in Bolivia, and opened centers in Spain, Mexico, and Iraq. The global effort to reduce suffering is achieved one facility at a time, through the dedication of scientists, doctors, and researchers who believe in the untapped and often inaccessible potential of stem cell regenerative technology. 

To learn more about the Stem Cell Center, visit their website here: https://stemcellcenter.net/about/